HWM
GILD icon

HighMark Wealth Management’s Gilead Sciences GILD Stock Holding History

HighMark Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.4K Buy
217
+51
+31% +$6.72K 0.01% 227
2026
Q1 		$23.2K Hold
166
– – 0.01% 220
2025
Q4 		$20.3K Buy
166
+1
+0.6% +$122 0.01% 237
2025
Q3 		$18.3K Sell
165
-6
-4% -$682 0.01% 242
2025
Q2 		$18.9K Buy
171
+1
+0.6% +$106 0.01% 229
2025
Q1 		$19.1K Sell
170
-10
-6% -$1.03K 0.01% 202
2024
Q4 		$16.6K Buy
180
+62
+53% +$5.58K 0.01% 222
2024
Q3 		$9.91K Buy
118
+1
+0.9% +$76 0.01% 302
2024
Q2 		$8.04K Buy
117
+1
+0.9% +$67 ﹤0.01% 321
2024
Q1 		$10.9K Buy
116
+1
+0.9% +$77 0.01% 263
2023
Q4 		$9.29K Buy
115
+1
+0.9% +$78 0.01% 274
2023
Q3 		$8.51K Buy
114
+2
+2% +$154 0.01% 276
2023
Q2 		$8.67K Buy
112
+1
+0.9% +$80 0.01% 277
2023
Q1 		$9.24K Buy
111
+1
+0.9% +$83 0.01% 308
2022
Q4 		$9.47K Buy
110
+1
+0.9% +$79 0.01% 265
2022
Q3 		$7K Buy
109
+1
+0.9% +$63 0.01% 287
2022
Q2 		$7K Buy
108
+1
+0.9% +$62 0.01% 297
2022
Q1 		$6K Buy
107
+1
+0.9% +$64 ﹤0.01% 337
2021
Q4 		$8K Buy
106
+1
+1% +$69 0.01% 292
2021
Q3 		$7K Buy
105
+1
+1% +$70 0.01% 300
2021
Q2 		$7K Buy
104
+2
+2% +$134 0.01% 305
2021
Q1 		$7K Buy
102
+1
+1% +$64 0.01% 294
2020
Q4 		$6K Buy
101
+1
+1% +$60 0.01% 302
2020
Q3 		$6K Buy
100
+1
+1% +$69 0.01% 294
2020
Q2 		$8K Buy
99
+1
+1% +$77 0.01% 237
2020
Q1 		$7K Sell
98
-220
-69% -$15.2K 0.01% 183
2019
Q4 		$20K Buy
+318
New +$20.7K 0.02% 129

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HighMark Wealth Management's GILD Position: Q2 2026 in Review

HighMark Wealth Management increased its Gilead Sciences (GILD) stake by 31% in Q2 2026, buying an estimated $6.72K and bringing the position to 217 shares worth $27.4K. The position accounts for 0.01% of the portfolio, ranked #227.

HighMark Wealth Management first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • HighMark Wealth Management held 217 shares of Gilead Sciences worth $27.4K as of Q2 2026.
  • HighMark Wealth Management bought 51 Gilead Sciences shares in Q2 2026, an estimated $6.72K.
  • Gilead Sciences made up 0.01% of HighMark Wealth Management's portfolio in Q2 2026, its #227 holding.
  • HighMark Wealth Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.